✦ LIBER ✦

Serum CA 19-9 as a Marker of Resectability and Survival in Patients with Potentially Resectable Pancreatic Cancer Treated with Neoadjuvant Chemoradiation

✍ Scribed by Matthew H. G. Katz; Gauri R. Varadhachary; Jason B. Fleming; Robert A. Wolff; Jeffrey E. Lee; Peter W. T. Pisters; Jean-Nicolas Vauthey; Eddie K. Abdalla; Charlotte C. Sun; Huamin Wang; Christopher H. Crane; Jeffrey H. Lee; Eric P. Tamm; James L. Abbruzzese; Douglas B. Evans

Book ID: 111773469
Publisher: Springer
Year: 2010
Tongue: English
Weight: 326 KB
Volume: 17
Category: Article
ISSN: 1068-9265
DOI: 10.1245/s10434-010-0943-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum carbohydrate antigen 19-9 represen

Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

✍ Tzeng, Ching-Wei D.; Balachandran, Aparna; Ahmad, Mediha; Lee, Jeffrey E.; Krish 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Prognostic Impact of Perioperative Serum

Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer

✍ Naru Kondo; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Takeshi Sudo 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 233 KB

Prognostic Impact of Postoperative Serum

Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer

✍ Shojiro Hata; Yoshihiro Sakamoto; Yusuke Yamamoto; Satoshi Nara; Minoru Esaki; K 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 247 KB

Serum ca 50 as a tumor marker in pancrea

Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9

✍ Caj Haglund; Pentti Kuusela; Hannu Jalanko; Peter J. Roberts 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 459 KB

CA 50 is a new tumor marker based on a monoclonal anti-carcinoid tumor, 2 cystadenocarcinomas, 2 anaplastic carcibody (MAb) against a human colorectal carcinoma cell line.The nomas, 15 poorly differentiated and 39 well-to moderately-CA 50 antigen is similar, but not identical, to the tumor different

Prognostic Impact of CA 19-9 on Outcome

Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer

✍ Combs, Stephanie E.; Habermehl, Daniel; Kessel, Kerstin A.; Bergmann, Frank; Wer 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 389 KB

CA19-9 as a predictor of tumor response

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

✍ Nazik HAMMAD; Lance K HEILBRUN; Philip A PHILIP; Anthony F SHIELDS; Mark M ZALUP 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB